Nissan Medical Industries Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Hezi Nissan
Chief executive officer
₪2.5m
Total compensation
| CEO salary percentage | 22.8% |
| CEO tenure | 41.9yrs |
| CEO ownership | n/a |
| Management average tenure | 16.8yrs |
| Board average tenure | 12.9yrs |
Recent management updates
Shareholders May Be Wary Of Increasing Nissan Medical Industries Ltd's (TLV:NISA) CEO Compensation Package
Dec 18
What Can We Conclude About Nissan Medical Industries' (TLV:NISA) CEO Pay?
Dec 11
Recent updates
Shareholders May Be Wary Of Increasing Nissan Medical Industries Ltd's (TLV:NISA) CEO Compensation Package
Dec 18Nissan Medical Industries (TLV:NISA) Shareholders Will Want The ROCE Trajectory To Continue
Nov 29We Think Nissan Medical Industries (TLV:NISA) Can Stay On Top Of Its Debt
Aug 29We Think Nissan Medical Industries' (TLV:NISA) Profit Is Only A Baseline For What They Can Achieve
Mar 27Nissan Medical Industries (TLV:NISA) Has A Somewhat Strained Balance Sheet
Mar 18Nissan Medical Industries (TLV:NISA) Will Be Hoping To Turn Its Returns On Capital Around
Nov 30Calculating The Intrinsic Value Of Nissan Medical Industries Ltd (TLV:NISA)
Oct 26Calculating The Intrinsic Value Of Nissan Medical Industries Ltd (TLV:NISA)
Dec 14Is Nissan Medical Industries (TLV:NISA) Using Too Much Debt?
Nov 09Is Nissan Medical Industries (TLV:NISA) Using Too Much Debt?
Jan 03Do Nissan Medical Industries's (TLV:NISA) Earnings Warrant Your Attention?
May 07Under The Bonnet, Nissan Medical Industries' (TLV:NISA) Returns Look Impressive
Apr 14Does Nissan Medical Industries (TLV:NISA) Have A Healthy Balance Sheet?
Mar 27Nissan Medical Industries (TLV:NISA) Shareholders Have Enjoyed An Impressive 227% Share Price Gain
Mar 09Is Nissan Medical Industries Ltd.'s (TLV:NISA) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 18Does Nissan Medical Industries (TLV:NISA) Deserve A Spot On Your Watchlist?
Feb 01Should We Be Excited About The Trends Of Returns At Nissan Medical Industries (TLV:NISA)?
Jan 13Is Nissan Medical Industries (TLV:NISA) Using Too Much Debt?
Dec 26What Can We Conclude About Nissan Medical Industries' (TLV:NISA) CEO Pay?
Dec 11Introducing Nissan Medical Industries (TLV:NISA), A Stock That Climbed 89% In The Last Year
Nov 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₪19m |
| Jun 30 2024 | n/a | n/a | ₪19m |
| Mar 31 2024 | n/a | n/a | ₪18m |
| Dec 31 2023 | ₪2m | ₪569k | ₪6m |
| Sep 30 2023 | n/a | n/a | -₪9m |
| Jun 30 2023 | n/a | n/a | -₪35m |
| Mar 31 2023 | n/a | n/a | -₪38m |
| Dec 31 2022 | ₪2m | ₪579k | -₪36m |
| Sep 30 2022 | n/a | n/a | -₪24m |
| Jun 30 2022 | n/a | n/a | -₪483k |
| Mar 31 2022 | n/a | n/a | ₪16m |
| Dec 31 2021 | ₪2m | ₪561k | ₪36m |
| Sep 30 2021 | n/a | n/a | ₪49m |
| Jun 30 2021 | n/a | n/a | ₪66m |
| Mar 31 2021 | n/a | n/a | ₪67m |
| Dec 31 2020 | ₪3m | ₪561k | ₪57m |
| Sep 30 2020 | n/a | n/a | ₪42m |
| Jun 30 2020 | n/a | n/a | ₪30m |
| Mar 31 2020 | n/a | n/a | ₪13m |
| Dec 31 2019 | ₪2m | ₪593k | ₪16m |
| Sep 30 2019 | n/a | n/a | ₪22m |
| Jun 30 2019 | n/a | n/a | ₪24m |
| Mar 31 2019 | n/a | n/a | ₪32m |
| Dec 31 2018 | ₪3m | ₪575k | ₪25m |
| Sep 30 2018 | n/a | n/a | ₪27m |
| Jun 30 2018 | n/a | n/a | ₪24m |
| Mar 31 2018 | n/a | n/a | ₪16m |
| Dec 31 2017 | ₪3m | ₪1m | ₪13m |
Compensation vs Market: Hezi's total compensation ($USD676.40K) is above average for companies of similar size in the IL market ($USD423.97K).
Compensation vs Earnings: Hezi's compensation has been consistent with company performance over the past year.
CEO
Hezi Nissan (67 yo)
41.9yrs
Tenure
₪2,492,000
Compensation
Mr. Yeheskel Nissan, also known as Hezi, has been the Chief Executive Officer at Nissan Medical Industries Ltd. since 1983 and serves as its Director 1996 and serves as its Managing Director. Mr. Nissan se...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Director | 41.9yrs | ₪2.49m | no data | |
| Company Technologist | no data | ₪876.00k | no data | |
| Vice President of Business Development & Products at Sfantak | 16.8yrs | ₪905.00k | no data | |
| Chief Financial Officer | 2.5yrs | ₪829.00k | no data | |
| Manager of the Subsidiary Production Site | no data | ₪886.00k | no data |
16.8yrs
Average Tenure
66yo
Average Age
Experienced Management: NISA's management team is seasoned and experienced (16.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Director | 28.9yrs | ₪2.49m | no data | |
| Independent Director | 12.9yrs | no data | no data | |
| Chairman of the Board | 21.9yrs | no data | no data | |
| Independent Director | 9.9yrs | no data | no data | |
| Independent Director | 9.9yrs | no data | no data |
12.9yrs
Average Tenure
65yo
Average Age
Experienced Board: NISA's board of directors are seasoned and experienced ( 12.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/29 04:34 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nissan Medical Industries Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|